CDK4 and Arthritis: Because the inhibition of CDK4/6 reduced the excess MMPs induced by cytokines from synovial fibroblasts, the combination use of CDKI with anti-inflammatory agents such as biologic agents might be an ideal therapeutic strategy as we have previously shown in an animal model of arthritis [19].